Antiviral drugs and plasma therapy used for Covid-19 treatment: a nationwide Turkish algorithm

Drug Metab Rev. 2020 Nov;52(4):531-539. doi: 10.1080/03602532.2020.1803907. Epub 2020 Aug 6.

Abstract

The Coronavirus outbreak described as COVID-19 is an insidious and enormous biohazard which began to be noticed in November 2019. When the virus was determined to cause serious upper respiratory tract infections resulting in death, pandemics were declared in the world. As of today, the number of cases exceeded 221 thousand people in Turkey, the number of patients who died had reached 5526. In more than 200 countries around the world, 15.1 million people fight the disease, while the number of people recovered is over 9.134 million, and the number of deaths has exceeded 620 thousand. The top 5 countries in the world are USA, Brazil, Russia, India and Spain. The countries with the highest number of cases after America (approximately 4 million 28 thousand) are Brazil (approximately 2 million 166 thousand), India (about 1 million 195 thousand), Russia (approximately 789 thousand), South Africa (approximately 382 thousand). In addition, the number of deaths and cases caused by Covid 19 continues to increase day by day. In this review, it was aimed to discuss that Covidien-19 against antiviral drugs used in the struggle across the globe and plasma treatment options about the current state of knowledge and Turkey algorithm by comparing the therapeutic treatment options.

Keywords: Antiviral drugs; COVID-19; Turkey algorithm; plasma treatment.

Publication types

  • Review

MeSH terms

  • Algorithms
  • Antiviral Agents* / classification
  • Antiviral Agents* / pharmacology
  • Betacoronavirus / drug effects
  • Betacoronavirus / physiology
  • COVID-19
  • COVID-19 Drug Treatment
  • COVID-19 Serotherapy
  • Coronavirus Infections* / drug therapy
  • Coronavirus Infections* / epidemiology
  • Coronavirus Infections* / therapy
  • Humans
  • Immunization, Passive / methods
  • Pandemics*
  • Pneumonia, Viral* / drug therapy
  • Pneumonia, Viral* / epidemiology
  • SARS-CoV-2
  • Turkey

Substances

  • Antiviral Agents